Cargando…

A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models

B cell lymphoma (BCL) is the most frequently diagnosed type of non-Hodgkin lymphoma (NHL), and accounts for about 4% of all cancers in the USA. Kinases spleen tyrosine kinase (Syk), Src, and Janus kinase 2 (JAK2) have been thought as potential targets for the treatment of BCL. We have recently devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Nannan, Zhang, Guo, Liu, Ning, Lin, Wanting, Ji, Sen, Zheng, Mingwu, Chen, Kai, Liang, Xiao, Li, Guobo, Ma, Yu, Zhu, Jun, Niu, Ting, Li, Lin-Li, Li, Jiong, Wei, Yu-Quan, Yang, Sheng-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762338/ https://www.ncbi.nlm.nih.gov/pubmed/29340070 http://dx.doi.org/10.18632/oncotarget.22847

Ejemplares similares

P1009: SKLB054, A NOVEL JAK2 INHIBITOR, POTENTLY TREATS MYELOPROLIFERATIVE NEOPLASM WITH JAK2V617F MUTATION
por: Zhao, Ailin, et al.
Publicado: (2023)

SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML
por: Ma, Shuang, et al.
Publicado: (2015)

SKLB1002, a potent inhibitor of VEGF receptor 2 signaling, inhibits endothelial angiogenic function in vitro and ocular angiogenesis in vivo
por: Zhang, Qiu-Yang, et al.
Publicado: (2020)

SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway
por: Peng, X, et al.
Publicado: (2014)

Protective effects of SKLB023 on a mouse model of unilateral ureteral obstruction by the modulation of gut microbiota
por: Feng, Yanhuan, et al.
Publicado: (2018)

Syk/Src Pathway-Targeted Inhibition of Skin Inflammatory Responses by Carnosic Acid
por: Oh, Jueun, et al.
Publicado: (2012)

Fisetin Suppresses Macrophage-Mediated Inflammatory Responses by Blockade of Src and Syk
por: Kim, Jun Ho, et al.
Publicado: (2015)

Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling
Publicado: (1994)

Preclinical pharmacodynamic evaluation of drug candidate SKLB-178 in the treatment of non-small cell lung cancer
por: Zhong, Lei, et al.
Publicado: (2017)

SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta/Smad signaling pathway
por: Zhang, Jinhang, et al.
Publicado: (2018)

Regulation of Discrete Functional Responses by Syk and Src Family Tyrosine Kinases in Human Neutrophils
por: Ear, Thornin, et al.
Publicado: (2017)

ST5 Positively Regulates Osteoclastogenesis via Src/Syk/Calcium Signaling Pathways
por: Kim, Min Kyung, et al.
Publicado: (2019)

Simultaneous inhibition of JAK and SYK kinases ameliorates chronic and destructive arthritis in mice
por: Llop-Guevara, Alba, et al.
Publicado: (2015)

SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling
por: Barzegar, Mansoureh, et al.
Publicado: (2017)

Mixed micelles loaded with the 5-benzylidenethiazolidine-2,4-dione derivative SKLB023 for efficient treatment of non-alcoholic steatohepatitis
por: Li, Yanping, et al.
Publicado: (2019)

SKLB023 hinders renal interstitial fibrosis in obstructive nephropathy by interfering TGF-β1/Smad3 signaling
por: Feng, Yanhuan, et al.
Publicado: (2018)

A novel multikinase inhibitor SKLB‐YTH‐60 ameliorates inflammation and fibrosis in bleomycin‐induced lung fibrosis mouse models
por: Liu, Hongyao, et al.
Publicado: (2021)

MPC850 integrated communications microprocessor : user's manual.
Publicado: (1998)

SKLB023 protects mice against acute liver injury by inhibiting proinflammatory cytokine production in both T cells and macrophages
por: Yu, Jia, et al.
Publicado: (2018)

Sonata in D, D. 850, op. 53
por: Schubert, Franz, 1797-1828
Publicado: (1993)

ATP-Binding Pocket-Targeted Suppression of Src and Syk by Luteolin Contributes to Its Anti-Inflammatory Action
por: Lee, Jeong-Oog, et al.
Publicado: (2015)

Differential Requirements for Src-Family Kinases in SYK or ZAP70-Mediated SLP-76 Phosphorylation in Lymphocytes
por: Fasbender, Frank, et al.
Publicado: (2017)

Dehydroabietic Acid Suppresses Inflammatory Response Via Suppression of Src-, Syk-, and TAK1-Mediated Pathways
por: Kim, Eunji, et al.
Publicado: (2019)

Annealing effects of 850 nm vertical-cavity surface-emitting lasers after proton irradiation
por: Chen, Jiawei, et al.
Publicado: (2022)

Efficacy of NS-018, a potent and selective JAK2/Src inhibitor, in primary cells and mouse models of myeloproliferative neoplasms
por: Nakaya, Y, et al.
Publicado: (2011)

SKLB023 Blocks Joint Inflammation and Cartilage Destruction in Arthritis Models via Suppression of Nuclear Factor-Kappa B Activation in Macrophage
por: Xie, Caifeng, et al.
Publicado: (2013)

Coordinate interactions of Csk, Src, and Syk kinases with αIIbβ3 initiate integrin signaling to the cytoskeleton
por: Obergfell, Achim, et al.
Publicado: (2002)

Inhibition of SYK and cSrc kinases can protect bone and cartilage in preclinical models of osteoarthritis and rheumatoid arthritis
por: Novikov, F. N., et al.
Publicado: (2021)

Synergistic Anti-Tumour Effect of Syk Inhibitor and Olaparib in Squamous Cell Carcinoma: Roles of Syk in EGFR Signalling and PARP1 Activation
por: Huang, Duen-Yi, et al.
Publicado: (2020)

A novel optical technology based on 690 nm and 850 nm wavelengths to assist needle thoracostomy
por: Lee, Chien-Ching, et al.
Publicado: (2021)

Syk, c-Src, the αvβ3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption
por: Zou, Wei, et al.
Publicado: (2007)

Platelet Adhesion to Podoplanin Under Flow is Mediated by the Receptor CLEC-2 and Stabilised by Src/Syk-Dependent Platelet Signalling
por: Navarro-Núñez, Leyre, et al.
Publicado: (2015)

Ranunculus bulumei Methanol Extract Exerts Anti-Inflammatory Activity by Targeting Src/Syk in NF-κB Signaling
por: Hong, Yo Han, et al.
Publicado: (2020)

Sauropus brevipes ethanol extract negatively regulates inflammatory responses in vivo and in vitro by targeting Src, Syk and IRAK1
por: Kim, Ji Hye, et al.
Publicado: (2021)

A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas
por: Munshi, Manit, et al.
Publicado: (2022)

ArtinM Cytotoxicity in B Cells Derived from Non-Hodgkin’s Lymphoma Depends on Syk and Src Family Kinases
por: Barboza, Bruno Rafael, et al.
Publicado: (2023)

Combined Targeting of JAK2 and Bcl-2/Bcl-xL to Cure Mutant JAK2-Driven Malignancies and Overcome Acquired Resistance to JAK2 Inhibitors
por: Waibel, Michaela, et al.
Publicado: (2013)

Epidemiological characteristics, clinical manifestations and laboratory findings in 850 patients with brucellosis in Heilongjiang Province, China
por: Jiang, Wenhui, et al.
Publicado: (2019)

Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC
por: Li, Mingzhu, et al.
Publicado: (2023)

Real driving emissions data: Isuzu FTR850 AMT
por: Joubert, Johan W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jhme0no94nv3oak3oh2u7im83d